Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstar Plc Regulatory News (TST)

Share Price Information for Touchstar Plc (TST)

Share Price is delayed by 15 minutes
Get Live Data
77.00    2.00 (2.67%)
Bid:
74.00
Ask:
80.00
Spread: 6.00 (8.108%)
Market Cap: £6.10m
TST Live PriceLast checked at - London Stock Exchange

Intraday Touchstar Plc Share Chart

Interim Results

3 Sep 2008 07:00

RNS Number : 5889C
Belgravium Technologies PLC
03 September 2008
Β 

ο»Ώ

ForΒ ImmediateΒ Release

3Β September 2008

Belgravium Technologies plc

Interim Results for the Six Months ended 30 June 2008

The Board of Belgravium Technologies plc ('Belgravium' or 'the Group'), designers and manufacturers of real-time data capture systems, is pleased toΒ announce Interim results for the six months ended 30 June 2008.

Key Financials:Β 

Β 

30 June 2008

Β 

30 June 2007

Β 

Turnover

Β£3,942,000

Β£5,222,000

Profit before tax

Β£72,000

Β£1,024,000

Earnings per share

0.05p

0.71p

Operational Overview:

Strong recurring service, licence and maintenance revenue has offset reduction in new contracts secured during first halfΒ 

Commercial emphasis on software and support services in H2

Belgravium's technology still required to improve customers; efficiency, cost control and growth

Belgravium well positioned to capitalise in key sectors as markets recover

Commenting today, Executive Chairman John Kembery said:

"The economic downturn has impacted our growth strategy more heavily than originally anticipated. On account of this we have seen a weak first half.

However, Belgravium provides a key service to its customers and whilst it is prudent to initially cut back in such economic conditions, customers cannot negate quality of service to their customers indefinitely. We are confident that our offering remains valuable and we cautiously expect a recovery at the end of 2008 and into 2009 as market conditions improve and customers reassess the value of our services taking a longer term view."

For further information please contact:

Buchanan Communications Ltd

Suzanne Brocks

Christian Goodbody

020 7466 5000

Belgravium Technologies Plc

John Kembery

Mob: 07770 731021

WH IrelandΒ 

Gary Marshall

0113 394 6610

KPMG Corporate Finance

Christian Mayo

0161 246 4000

Β 

Chairman's Statement

Results

Following a successful year for Belgravium in 2007, we arrive at the first half year end in 2008, in a very different economic climate, experienced the world over.

We reported in an update on trading at the time of our AGM in May 2008, that given suchΒ a climate, we had experienced a slowdown in trading, specifically in the number of forward order contracts secured which we believed would result in a first half result below expectations.

In the half year ended 30 June 2008,Β sales totalled Β£3,942,000 compared with Β£5,222,000 in the first half of 2007. Accordingly,Β profit before tax fell from Β£1,024,000Β at the half yearΒ in 2007 to Β£72,000Β in 2008Β resulting inΒ basic earnings per ordinary shareΒ ofΒ 0.05p per share against 0.71p per share in 2007.

Operational Review

At the end of 2007 we reported that the Company had made good progressΒ inΒ its growth strategy and that there were attractive projects in the pipeline which would contribute to organic growth in 2008 and beyond. As a result of a deterioration in the global economy experienced across many sectors,Β new businessΒ generation has been difficultΒ in the first half of 2008 and the shortfall in sales has had a direct effect on profitability. Expected projects haveΒ notΒ been lost or abandoned, ratherΒ customers have decided to re-examine, modify or postpone their plansΒ leadingΒ to a series of delays. Our installations areΒ generally consideredΒ capital projects and the general lack of confidence hasΒ led to a reluctance to commit to capital spend. We view this situation as a deferment of orders rather than a cancellation and we have maintained our market share with no loss of orders to competitors.

The strong recurring nature of the Group's service, licence and maintenance revenue has helped to offset the reduction in new contracts secured during the first half.

The Market

Uncertain trading conditions have been experiencedΒ acrossΒ the whole ofΒ ourΒ industry.Β Belgravium is, however, well positioned to respond to this challenge andΒ itΒ reinforcesΒ our view that commercial emphasis shouldΒ fallΒ on software and support services. This approach offers more repeat business and better operating margins.

There is ample evidence that our systems improve customer efficiency,Β costΒ controlΒ and marginΒ growth. We believe our clientsΒ will need to retain their competitive edgeΒ and cannot deferΒ these advantagesΒ indefinitely.

As the marketΒ begins to recover,Β BelgraviumΒ is extremely well positioned toΒ capitalise on the market sectors it hasΒ successfullyΒ developed.

Strategy

A year agoΒ we stated that weΒ intendedΒ to changeΒ ourΒ emphasis from hardware to software systems and support services. Despite changes to economicΒ conditions, this policy remains appropriate forΒ the longer termΒ success of the Group. We continue to place great emphasis on new product development andΒ maximisedΒ salesΒ both within and outside theΒ UK. We shall, of course, restrain costs wherever possible but mustΒ maintain our excellent service by continuing our employment ofΒ high quality technical and sales staff.Β 

Balance Sheet

We are pleased to report that total borrowings have decreased from Β£1.96m as at 31 December 2007 to Β£1.75m at 30 June 2008 as we pay down the term loan used to finance the acquisition of Touchstar. We are currentlyΒ retiringΒ this facility at a rate of Β£500,000 per annum.

Inventories were higher than usual at the end of the first half reflecting the typically long lead times of electronic components for our systems.Β Β Trade receivables were almost the same as a year ago and have not flexed with lower sales because June was a comparatively strong month.

Dividend

The reduction inΒ profitΒ in the first halfΒ meansΒ it is not prudent forΒ BelgraviumΒ to payΒ an interim dividend in 2008. The DirectorsΒ areΒ committedΒ toΒ resuming aΒ dividend paymentΒ as soonΒ as possibleΒ once financial conditions permit.

Acquisitions

We continue to review possible acquisition opportunities. However these will only be pursued where they can demonstrate significant incremental shareholder value.Β The BoardΒ continuesΒ to exploreΒ every opportunity,Β whilstΒ takingΒ aΒ realisticΒ viewΒ onΒ funding requirements andΒ currentΒ market conditions.

Outlook

Belgravium GroupΒ occupiesΒ strong positionsΒ in its chosenΒ marketΒ sectorsΒ and offers customers unique solutions to improve productivity and efficiencies in the supply chain. Whilst the first half of 2008Β witnessed a lengthening of the normal sales cycle,Β Belgravium'sΒ strength,Β reputation, proven product range and dedicated teamΒ will allow progress to resume once market conditions improve.

Consolidated income statementΒ 

for the six months endedΒ 30 June 2008

Notes

6 months toΒ 

30 June 2008Β 

TotalΒ 

(Unaudited)

Β£'000

6 months toΒ 

30 June 2007Β 

TotalΒ 

(Unaudited)

Β£'000

Revenue

3,942

5,222

Operating Profit

129

1,101

Finance income

5

19

Finance costs

(62)

(96)

Profit before tax

72

1,024

Income tax expense

(22)

(307)

Profit for the periodΒ attributable to equity shareholders

50

717

Basic earnings per ordinary share (pence)

2

0.05

0.71

Diluted earning per ordinary share (pence)

2

0.05

0.71

Consolidated statement of changes in shareholders' equityΒ 

for the six months endedΒ 30 June 2008

Called up share capital (Unaudited)Β 

Β£'000

Share premium account (Unaudited) Β£'000

Capital redemption reserve (Unaudited) Β£'000

Retained earnings (Unaudited)Β 

Β£'000

Total

(Unaudited)

Β£'000

AtΒ 30 June 2007

5,037

2,929

2,100

(1,453)

8,613

New Shares Issued

10

3

-

-

13

Profit

-

-

-

702

702

Equity Dividends

-

-

-

(141)

(141)

AtΒ 31 December 2007

5,047

2,932

2,100

(892)

9,187

Profit

-

-

-

50

50

Equity Dividends

-

-

-

(384)

(384)

AtΒ 30 June 2008

5,047

2,932

2,100

(1,226)

8,853

Β Β  Consolidated balance Sheet

at 30 June 2008

As at

30 June 2008Β (Unaudited)

Β£'000

As atΒ 

30 June 2007Β (Unaudited)Β 

Β£'000

At at

31 December 2007Β (Audited)

Β£'000

Non-current assets

Intangible Assets

Goodwill

9,124

9,124

9,124

Development expenditure

271

193

267

Property, plant and equipment

304

308

251

Deferred tax asset

7

27

7

9,706

9,652

9,649

Current assets

Inventories

1,497

1,078

1,262

Trade and other receivables

2,518

2,585

3,901

Cash and cash equivalents

1

590

2

4,016

4,253

5,165

Current liabilities

Trade and other payables

2,871

2,521

3,145

Current corporation tax liabilities

205

475

472

Financial liabilities: Borrowings

789

1,000

1,214

Provision for other liabilities and charges

46

46

46

3,911

4,042

4,877

Net Current assets

105

211

288

Non current liabilities

Financial liabilities: Borrowings

958

1,250

750

Net Assets

8,853

8,613

9,187

Shareholders' equity

Share capital

5,047

5,037

5,047

Share premium reserve

2,932

2,929

2,932

Capital redemption reserve

2,100

2,100

2,100

Profit and loss account

(1,226)

(1,453)

(892)

Total equity

8,853

8,613

9,187

Β Β  Consolidated cash flow statement

For 6 months toΒ 30 June 2008

6 months toΒ 

30 June 2008Β (Unaudited) Β£'000

6 months toΒ 

30 June 2007Β (Unaudited) Β£'000

Cash flows from operating activities

Operating profit

129

1,101

Depreciation

66

89

Amortisation

55

32

Movement in:

Provisions

-

(5)

Inventories

(235)

79

Trade and other receivables

1,383

715

Trade and other payables

(278)

(452)

Cash generated from operations

1,120

1,559

Interest received

5

17

Interest paid

(58)

(98)

Corporation tax paid

(289)

(156)

Net cash generated from operating activities

778

1,322

Cash flows from investing activities

Expenditure of intangible fixed assets

(59)

(24)

Purchase of property, plant and equipment

(119)

(36)

Net cash used in investing activities

(178)

(60)

Cash flows from financing activities

Proceeds from issuance of ordinary shares

-

30

Repayment of bank borrowings

(292)

(500)

Dividends paid to company's ordinary shareholders

(384)

(363)

Repayment of capital on finance leases

-

(10)

Net cash used in financing activities

(676)

(843)

Net (decrease)/increase in cash and cash equivalents

(76)

419

Cash, cash equivalents and bank overdrafts at the beginning of the period

(212)

171

Cash, cash equivalents and bank overdrafts at the end of the period

(288)

590

Β Β 

Notes to the interim report

For 6 months toΒ 30Β June 2008

1.

This financial information comprises the consolidated interim balance sheet as at 30 June 2008 and 30 June 2007 and related consolidated interim statement of income and cash flows for the six months then ended of Belgravium Technologies plc (hereinafter referred to as 'financial information'). The interim consolidated financial statements for the half year ended 30Β June 2008Β areΒ neither audited nor reviewed by the auditorsΒ and do not comprise statutory accounts within the meaning of section 240 of the Companies Act 1985. These interim financial statements were approved by the Board on 2 September 2008.

These interim financial statements have been prepared in accordance withΒ pronouncements on interim reporting issued by the ASB and the accounting policies set out in the 2007 annual report and financial statements which are prepared in accordance with IFRS as adopted by the European Union. The Group has chosen not to adopt IAS 34Β 'Interim financial statements' in preparing its interim statements. The financial statements have been prepared under the historical cost convention.

The audited accounts for the year ended 31 December 2007 upon which the auditors issued an unqualified opinion, have been delivered to the Registrar of Companies. The audit report on the 2007 accounts did not contain an emphasis of matter paragraph and did not contain a statement made under section 237 of the Companies Act 1985.

2.

Earnings per ordinary share

2008

(Unaudited)

Β£

2007

(Unaudited)

Β£

Basic earnings per ordinary share

0.05p

0.71p

Diluted earnings per ordinary share

0.05p

0.71p

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary share outstanding during theΒ period.

For diluted earnings per share the weighted average number of ordinary share in issue is adjusted to assume conversion of all dilutive ordinary shares. The dilutive ordinary shares represent the share options and warrants granted to employees where the exercise price is less than the average market price of the Company's ordinary shares during the period.

2008Β 

(Unaudited)

2007

(Unaudited)

Earnings

Β£'000

Weighted average number of sharesΒ 

(in thousands)

Earnings

Β£'000

WeightedΒ 

average number of shares (in thousands)

Basic EPS

Earnings attributable to ordinary shareholders

50

100,937

717

100,541

Effect of dilutive securities

Options

-

16

-

461

Diluted EPS

Adjusted earnings

50

100,953

717

101,002

3.

The Company did not declare any dividends in the half year endedΒ 30 June 2008

4.

Copies of this statement will be posted to shareholders and further copies will be made available to the public at the Company's office:-Β 2 Campus Road,Β ListerhillsΒ ScienceΒ Park, Bradford,Β West Yorkshire, BD7 1HR, or can be obtained from our website at www.belgravium-IR.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR LTMFTMMBMBIP
Date   Source Headline
11th Jan 201711:25 amRNSHolding(s) in Company
11th Jan 20178:15 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSTrading Update
3rd Jan 20179:00 amRNSHolding(s) in Company
5th Dec 20168:05 amRNSHolding(s) in Company
28th Sep 20167:00 amRNSHalf-year Report
11th Jul 201612:00 pmRNSCompletion of Capital Reorganisation
24th Jun 201612:01 pmRNSDirector/PDMR Shareholding
26th May 20169:31 amRNSHolding(s) in Company
24th May 201610:25 amRNSResult of AGM and GM
28th Apr 20167:00 amRNSNotice of GM
7th Apr 20167:00 amRNSPreliminary Results
22nd Mar 20167:00 amRNSNotice of Results
28th Oct 20157:00 amRNSDirectorate Change
29th Sep 20157:01 amRNSDirectorate Change
28th Sep 201511:48 amRNSHolding(s) in Company
21st Sep 20157:00 amRNSHalf Yearly Report
23rd Jun 20157:00 amRNSDirectorate Change
22nd Jun 20159:00 amRNSDirector/PDMR Shareholding
3rd Jun 20159:07 amRNSHolding(s) in Company
28th May 20157:00 amRNSAGM Statement and Directorate Appointment
21st Apr 201511:45 amRNSAnnual Report and Accounts
4th Mar 20157:00 amRNSFinal Results
6th Jan 20152:00 pmRNSCompletion of acquisition
4th Dec 20147:00 amRNSAcquisition and Trading Update
3rd Sep 20147:00 amRNSHalf Yearly Report
25th Jul 20147:00 amRNSTrading Statement
11th Jul 20143:22 pmRNSStatement regarding Belgravium Technologies plc
11th Jul 20142:52 pmRNSForm 8.3 - Belgravium Technologies PLC
9th Jul 201412:15 pmPRNForm 8.3 - Trakm8 Holdings Plc
9th Jul 201411:15 amRNSForm 8 (OPD) Belgravium Technologies PLC
9th Jul 201410:36 amRNSForm 8.5 (EPT/NON-RI)
9th Jul 20149:54 amRNSForm 8.3 - Belgravium Technologies plc
8th Jul 201411:32 amBUSForm 8.3 - BELGRAVIUM TECHNOLOGIES PLC
8th Jul 201410:32 amRNSForm 8.3 - Belgravium Technologies plc
8th Jul 20147:00 amRNSStatement re. Possible Offer for Belgravium Tech
7th Jul 20143:00 pmRNSStatement re. Possible Offer
9th Jun 201411:35 amRNSNovo IVC Announce iOS Software Release
29th May 20147:01 amRNSAGM Statement
29th May 20147:00 amRNSContract Award
23rd Apr 20144:03 pmRNSAnnual Report and Accounts
16th Apr 20147:00 amRNSContract Award
17th Mar 20141:43 pmRNSHolding(s) in Company
17th Mar 201411:51 amRNSHolding(s) in Company
17th Mar 201411:50 amRNSHolding(s) in Company
5th Mar 20147:00 amRNSFinal Results
10th Feb 20144:52 pmRNSNWC adopt TouchStar system
31st Jan 20147:00 amRNSTrading Statement
28th Jan 20143:08 pmRNSNew Android Mobile Computer Launched
10th Jan 20144:03 pmRNSmda adopt TouchStar Technologies solution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.